This is the authors' abstract. We don't add key points for this paper.
The three-dimensional structure of phosphoribosylglycinamide formyltransferase (10-formyltetrahydrofolate:5'-phosphoribosylglycinamide formyltransferase, EC 2.1.2.2) has been solved both as an apoenzyme at 2.8-A resolution and as a ternary complex with the substrate glycinamide ribonucleotide and a folate inhibitor at 2.5-A resolution. The structure is a modified doubly wound alpha/beta sheet with flexibility in the active site, including a disordered loop in the apo structure, which is ordered in the ternary complex structure. This enzyme is a target for anti-cancer therapy and now for structure-based drug design.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Almassy et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: